Flagship Harbor Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Flagship Harbor Advisors's ARKG Position: Q1 2026 in Review
Flagship Harbor Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 5,747 shares — an estimated $167K sold.
Flagship Harbor Advisors first reported a position in ARKG in Q3 2018 and held it in 14 quarters. The position peaked at $549K in Q1 2021. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Flagship Harbor Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- Flagship Harbor Advisors sold 5,747 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $167K.
- Flagship Harbor Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 14 quarters.
- Flagship Harbor Advisors's ARK Genomic Revolution ETF position peaked at $549K in Q1 2021.
- 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.